View Older Stories

Aug 25, 2026 06:58AM Oppenheimer Upgrades Capricor Therapeutics (CAPR) to Outperform 'on Approval Optimism'

Aug 24, 2026 12:16PM Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

Aug 24, 2026 10:54AM Increasing unusual put volume: CAPR EYPT WPM ROST CBRG LNC FVRR IOT IOVA PR BNTX TEVA HWM MRNA BLSH BMNU

Aug 24, 2026 10:20AM FDA extends Capricor deramiocel review to November 22, HC Wainwright comments

Aug 21, 2026 04:55PM Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

Aug 21, 2026 07:47AM Kaos Capital pushes for board changes at Capricor Therapeutics

Aug 19, 2026 04:32PM Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

Aug 17, 2026 11:53AM Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

Aug 17, 2026 05:22AM Increasing unusual put option volume: IHI CAPR BW CPRT FIGR BKR VIK MXEF AMPG CRGY PAGP

Aug 14, 2026 03:43PM Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

Aug 14, 2026 02:50AM Cantor Fitzgerald Upgrades Capricor Therapeutics (CAPR) to Overweight

Aug 13, 2026 04:07PM Capricor Therapeutics (CAPR) Misses Q2 EPS by 10c

Aug 13, 2026 03:41PM Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

Aug 11, 2026 12:18PM CAPR INVESTOR ALERT: Capricor Therapeutics Securities Class Action Filed; September 28, 2026 Lead Plaintiff Deadline - Kehoe Law Firm

Aug 10, 2026 01:44PM Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

Aug 7, 2026 02:43PM Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

Aug 3, 2026 03:04PM Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

Jul 31, 2026 09:00AM CAPR INVESTIGATION: Block & Leviton Seeks to Speak With Capricor Therapeutics Investors

Jul 30, 2026 04:32PM Jones Trading Downgrades Capricor Therapeutics (CAPR) to Hold

Jul 30, 2026 10:39AM Increasing unusual put volume: CAPR SFM EXE TEVA WMB IRM TRV BXSL INSM AAP CI RSP KORU ALT CHKP FITB TDOC WOLF

Jul 30, 2026 08:42AM Maxim Group Downgrades Capricor Therapeutics (CAPR) to Hold

Jul 30, 2026 07:54AM Oppenheimer Downgrades Capricor Therapeutics (CAPR) to Perform

Jul 30, 2026 07:32AM Ladenburg Thalmann Downgrades Capricor Therapeutics (CAPR) to Neutral

Jul 30, 2026 05:59AM H.C. Wainwright Downgrades Capricor Therapeutics (CAPR) to Neutral

Jul 30, 2026 02:52AM Piper Sandler Downgrades Capricor Therapeutics (CAPR) to Neutral

Jul 29, 2026 10:05AM The Lancet publishes Capricor's phase 3 DMD therapy trial results

Jul 29, 2026 07:45AM CAPR INVESTIGATION: Capricor Therapeutics Investors Should Contact Block & Leviton About Recovering Their Losses

Jul 29, 2026 03:54AM Increasing unusual call option volume: AVTR CAPR GLNG KORU MUU BCS JCI NRG

Jul 28, 2026 07:04AM Alliance Global Partners Downgrades Capricor Therapeutics (CAPR) to Neutral

Jul 28, 2026 06:22AM Increasing unusual put option volume: CAPR XLC CG METC CHYM AIQ BKR

Jul 27, 2026 03:47PM Roth/MKM Downgrades Capricor Therapeutics (CAPR) to Neutral

Jul 27, 2026 02:36PM Jones Trading on Capricor Therapeutics (CAPR): 'this is the first time we have seen the magnitude of difference in primary outcome'

Jul 27, 2026 12:31PM H.C. Wainwright on Capricor Therapeutics (CAPR): 'Cage Match Expected at Wednesday's AdCom as Drama with FDA Continues'

Jul 27, 2026 11:02AM B.Riley Downgrades Capricor Therapeutics (CAPR) to Neutral

Jul 27, 2026 10:48AM Increasing unusual put option volume: CAPR BETA UCO CRH BKR METC OTLK CIA TCOM EQNR

Jul 27, 2026 10:12AM Oppenheimer Reiterates Capricor Therapeutics (CAPR) at Outperform, 'like the risk-reward'

Jul 27, 2026 07:55AM Capricor Therapeutics (CAPR) Falls 26% Following FDA Briefing Docs Post

Jul 15, 2026 07:48AM Capricor Therapeutics (CAPR) Reiterated at Overweight by Cantor Fitzgerald

Jul 7, 2026 07:18AM Capricor Therapeutics (CAPR) Reiterates Overweight Rating Ahead of Upcoming PDUFA

Jun 29, 2026 05:58AM Capricor Therapeutics (CAPR) 4500 contracts of August 30 calls and 2900 contracts of August 20 puts trade

May 13, 2026 04:15AM B.Riley Reiterates Buy Rating on Capricor Therapeutics (CAPR)

May 12, 2026 04:13PM Capricor Therapeutics (CAPR) Misses Q1 EPS by 7c

May 8, 2026 07:15AM Capricor sues NS Pharma over Duchenne therapy distribution deal

Mar 13, 2026 07:30AM Capricor Therapeutics (CAPR) Reiterated at Overweight by Cantor Fitzgerald After Q4 Result

Mar 12, 2026 04:17PM Capricor Therapeutics (CAPR) Misses Q4 EPS by 11c

Mar 12, 2026 09:02AM Capricor reports positive HOPE-3 trial results for Duchenne therapy

Mar 10, 2026 10:37AM Jones Trading Reiterates Buy Rating on Capricor Therapeutics (CAPR) as FDA review resumed

Mar 10, 2026 10:05AM H.C. Wainwright Reiterates Buy Rating on Capricor Therapeutics (CAPR)

Mar 10, 2026 09:25AM FDA sets new PDUFA date for Capricor's Deramiocel therapy

Mar 9, 2026 07:46AM Truist on Head of CBER at FDA Exit: 'we anticipate a positive stock reaction for IRON CAPT RGNX QURE'

View Older Stories